Muhammad Suleman Ajmal, MBBS

Muhammad Ajmal practices at DaVita Med Center Dialysis in Houston, Texas.

Muhammad Ajmal's NPI, 1184873234, was assigned on September 13, 2008. Muhammad Ajmal graduated from Rawalpindi Medical College in 2005. Muhammad Ajmal holds Texas license P6763.

Muhammad Ajmal's primary practice is DaVita Med Center Dialysis, at 5610 Almeda, Houston, TX 77004 in Harris County. The practice phone is (713) 520-6878.

Muhammad Ajmal's primary practice is DaVita Med Center Dialysis in Houston, Texas. Muhammad Ajmal is also affiliated with Harris Health Ben Taub Hospital. The medical group on file is Sound Physicians. Dmand AI also links Muhammad Ajmal to 2 more hospitals, 3 medical groups and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Muhammad Ajmal practices, 5 sites in all. Vendor and product names are available with a free account.

Nephrology is Muhammad Ajmal's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Muhammad Ajmal is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Muhammad Ajmal's licenses on file in 3 states: Texas, Ohio and New Jersey.

Dmand AI lists acute kidney failure, chronic kidney disease and hypercalcemia among the conditions Muhammad Ajmal treats.

CMS data shows 874 Medicare services from Muhammad Ajmal across 8 procedure codes in 2024, for 228 Medicare patients. Medicare paid $70,648 for them.

CMS counts 228 Medicare patients who saw Muhammad Ajmal in 2024. The largest group is 65 to 74, with 78 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 30% are also on Medicaid. Their average risk score is 5.29, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Muhammad Ajmal's median patient age at 65, with 42% women.

In 2024, Muhammad Ajmal wrote 576 Medicare Part D claims for 99 patients. 84% of them were for generic drugs. CMS names the drug for 437 of them, across 15 drugs with 11 or more claims each, at $62,654 in total drug cost. In 2023, CMS named 306 claims across 11 drugs.

Muhammad Ajmal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Muhammad Ajmal, published from 2020 to 2021. 2020 was the busiest year, with 2. Muhammad Ajmal has published most often in Cureus. Muhammad Ajmal's most frequent co-authors are Carl Peter Walther, MD, Sehrish Ali, DO and Subhasis Chatterjee, MD.

CMS Open Payments shows 13 general payments to Muhammad Ajmal from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Fresenius USA Marketing, Inc. paid the most, $140.

Muhammad Ajmal graduated from Rawalpindi Medical College in 2005. Muhammad Ajmal is a member of ACP and ASN.

Muhammad Ajmal is in network with 23 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.